About senseonics holdings inc - SENS
Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
SENS At a Glance
Senseonics Holdings, Inc.
20451 Seneca Meadows Parkway
Germantown, Maryland 20876-7005
| Phone | 1-301-515-7260 | Revenue | 35.26M | |
| Industry | Electronic Components | Net Income | -69,113,000.00 | |
| Sector | Electronic Technology | 2025 Sales Growth | 56.893% | |
| Fiscal Year-end | 12 / 2026 | Employees | 130 | |
| View SEC Filings |
SENS Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 6.533 |
| Price to Book Ratio | 3.731 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -2.654 |
| Enterprise Value to Sales | 5.031 |
| Total Debt to Enterprise Value | 0.233 |
SENS Efficiency
| Revenue/Employee | 271,207.692 |
| Income Per Employee | -531,638.462 |
| Receivables Turnover | 2.836 |
| Total Asset Turnover | 0.311 |
SENS Liquidity
| Current Ratio | 4.827 |
| Quick Ratio | 4.552 |
| Cash Ratio | 3.875 |
SENS Profitability
| Gross Margin | 44.709 |
| Operating Margin | -193.825 |
| Pretax Margin | -196.026 |
| Net Margin | -196.026 |
| Return on Assets | -60.971 |
| Return on Equity | -168.267 |
| Return on Total Capital | -67.482 |
| Return on Invested Capital | -84.537 |
SENS Capital Structure
| Total Debt to Total Equity | 67.77 |
| Total Debt to Total Capital | 40.395 |
| Total Debt to Total Assets | 32.764 |
| Long-Term Debt to Equity | 66.958 |
| Long-Term Debt to Total Capital | 39.91 |